Form 4 for TRAX First Tracks Biotherapeutics, Inc.
Accepted 2026-09-04 16:25:39 ET · period of report 2026-09-02 · accession 0001715429-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-04 16:25 | 2026-09-02 | TRAX | Ware J. Anthony | Dir | M - OptEx | $5.74 | +39.3K | 54.9K | +251% | +$225.4K |
| D | 2026-09-04 16:25 | 2026-09-02 | TRAX | Ware J. Anthony | Dir | S - Sale+OE | $44.78 | -39.3K | 15.7K | -71% | -$1.76M |
| DM | 2026-09-04 16:25 | 2026-09-02 | TRAX | Ware J. Anthony | Dir | M - OptEx | $0.00 | -39.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-02 | M | A | 39,265 | $5.74 | 54,925 | D | — | — | |
| 2 | Common | Common Stock | 2026-09-02 | S | D | 39,265 | $44.78 | 15,660 | D | — | — | (F1) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.62 to $45.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (right to buy) | 2026-09-02 | M | D | 28,571 | $0.00 | 0 | D | $5.74 · — to 2027-08-21 | 28,571 Common Stock | (F2) The stock option is fully vested. |
| 4 | Derivative | Stock Option (right to buy) | 2026-09-02 | M | D | 10,694 | $0.00 | 0 | D | $5.74 · — to 2027-08-21 | 10,694 Common Stock | (F2) The stock option is fully vested. (F3) In addition to the shares the Reporting Person owns reported in Table I, the Reporting Person also holds additional options to purchase up to an aggregate of 99,320 shares of common stock and 6,500 restricted stock units. |